TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Husam A Alqaisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.